Summer 2026 Internship: Quality Control, Biomedical - Exton, PA jobs in United States
cer-icon
Apply on Employer Site
company-logo

dsm-firmenich · 1 week ago

Summer 2026 Internship: Quality Control, Biomedical - Exton, PA

dsm-firmenich is a global company dedicated to science, creativity, and sustainability. They are offering a Summer 2026 internship in Quality Control, Biomedical, where interns will assist with various quality control activities and gain hands-on experience in a professional environment.

BeautyChemicalHealth CareManufacturingNutrition

Responsibilities

Assist with Quality Control activities, including basic inspections, testing, data entry, and documentation of nonconformances
Support Document Control and Quality System processes by managing document changes, organizing records, and helping maintain ISO 13485 compliant files
Contribute to Product Release and Regulatory tasks, such as batch record reviews, technical file updates, labelling checks, audit preparation, etc
Participate in Engineering projects, including data collection for investigations (CAPA/NCR), supplier performance tracking, and continuous improvement initiatives

Qualification

Biomedical EngineeringISO 13485 complianceQuality Control activitiesData analysisCommunication skillsOrganizational skillsProblem-solving skillsInterpersonal skillsFlexibility

Required

Currently working on completion of a Bachelor's degree in Biomedical Engineering or related field
Must be available to work full-time on-site in Exton, PA beginning on June 1, 2026 and ending on August 14, 2026
Excellent communication and interpersonal skills
Strong analytical skills and ability to synthesize and parse data
Strong organizational, problem-solving, and analytical skills; able to manage priorities and workflow
Versatility, flexibility, and a willingness to work within constantly changing priorities with enthusiasm

Company

dsm-firmenich

company-logo
dsm-firmenich is a nutrition, health, and beauty pioneer and combines vital nutrients, flavors, and fragrances.

Funding

Current Stage
Public Company
Total Funding
$2.75B
2025-02-19Post Ipo Debt· $783.77M
2024-08-08Post Ipo Debt· $1.96B
2023-04-21IPO

Leadership Team

leader-logo
Jerry Vittoria
President Global Fine Fragrance
linkedin
Company data provided by crunchbase